Investigating a stock’s 52-week price history, covering the range of low and high prices, can provide significant information about its present state and future potential. Adaptive Biotechnologies Corp’s current trading price is -5.95% away from its 52-week high, while its distance from the 52-week low is 193.64%. The stock’s price range during this period has varied between $3.98 and $12.43. The company, active in the Healthcare sector, saw a trading volume of around 4.65 million for the day, considerably higher average daily volume of 1.85 million observed over the last three months.
Currently, the stock price of Adaptive Biotechnologies Corp (ADPT) is $11.69. In the most recent trading session, the stock underwent a significant upswing, peaking at $15.0 after opening at $11.69. The stock touched a low of $11.0 before closing at $11.05.
Adaptive Biotechnologies Corp had a pretty favorable run when it comes to the market performance.
How Financial Performance Impacts Market Capitalization
Adaptive Biotechnologies Corp (ADPT) has experienced a quarterly rise of 32.69% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.78B and boasts a workforce of 619 employees.
Decoding Analysts’ Ratings for Adaptive Biotechnologies Corp
As of right now, 4 analysts are rating Adaptive Biotechnologies Corp as a BUY, 3 of the polled analysts branded the stock as an OVERWEIGHT, 1 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
The Role of Moving Averages and Trading Volume in Technical Analysis
How ADPT’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for ADPT stands at 1.21. Similarly, the long-term debt-to-equity ratio is also 1.14.
ADPT Stock Stochastic Average
As of today, the raw stochastic average of Adaptive Biotechnologies Corp over the last 50 days is at 3.08%. This shows a declinee from the raw stochastic average of the previous 20 days, which was recorded at 5.50%. Further, the company’s Stochastic %K and %D values for the last 20 days were 8.12% and 7.84%, respectively.
ADPT Stock Price Performance Analysis
Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. This year’s metric has recorded a Price increase of 171.86%. However, over the past six months, we’ve seen a weaker performance of 58.62%. The price of ADPT leaped by -0.43% over the last 30 days. And in the last five days, it has surged by 11.97%.
